New Research on Dengue Prevention and Obesity/Diabetes Therapies Published

The New England Journal of Medicine has published new research, including findings on once-weekly mosnodenvir as a potential dengue prophylaxis in a human infection model. Additionally, studies on survodutide for obesity and type 2 diabetes, and retatrutide for obesity, were featured. These findings indicate progress in preventing dengue and advancing treatments for metabolic diseases.